2278 / 2894
2278
Anestesia por subespecialidades en el adulto
IV
110. Yusa T, Beckman JS, Crapo JD, Freeman BA: Hype-
roxia increases H
2
O
2
production by brain in vivo.
J Appl Physiol 63:353–358, 1987.
111. Clark JM, Lambertsen CJ: Rate of development of
pulmonary O
2
toxicity in man during O
2
breathing
at 2.0 Ata. J Appl Physiol 30:739–752, 1971.
112. Harabin AL, Homer LD, Weathersby PK, Flynn ET:
An analysis of decrements in vital capacity as an
index of pulmonary oxygen toxicity. J Appl Physiol
63:1130–1135, 1987.
113. Arieli R, Yalov A, Goldenshluger A: Modeling pul-
monary and CNS O
2
toxicity and estimation of
parameters for humans. J Appl Physiol 92:248–256,
2002.
114. Eckenhoff RG, Dougherty JH Jr, Messier AA, et al:
Progression and recovery of pulmonary oxygen
toxicity in humans exposed to 5 ATA air. Aviat
Space Environ Med 58:658–667, 1987.
115. Miller JN, Camporesi EM, McLeod M, Feezor M:
Studies of early pulmonary oxygen toxicity in man.
Anesthesiology 55(Suppl)A369, 1981.
116. Thorsen E, Aanderud L, Aasen TB: Effects of a stan-
dard hyperbaric oxygen treatment protocol on pul-
monary function. Eur Respir J 12:1442–1445, 1998.
117. Mathes DD: Bleomycin and hyperoxia exposure in
the operating room. Anesth Analg 81:624–629,
1995.
118. Bilfinger TV, Hartman AR: Acute pulmonary failure
with neoadjuvant protocol including mitomycin C
and surgical therapy. J Thorac Cardiovasc Surg
102:935, 1991.
119. Thompson CC, Bailey MK, Conroy JM, Bromley
HR: Postoperative pulmonary toxicity associated
with mitomycin C therapy. South Med J 85:1257–
1259, 1992.
120. Donald KW: Oxygen poisoning in man. I. BMJ
1:667–672, 1947.
121. Donald KW: Oxygen poisoning in man. II. BMJ
1:712–717, 1947.
122. Hampson N, Atik D: Central nervous system
oxygen toxicity during routine hyperbaric oxygen
therapy. Undersea Hyperb Med 30:147–153, 2003.
123. Hampson NB, Simonson SG, Kramer CC, Pianta-
dosi CA: Central nervous system oxygen toxicity
during hyperbaric treatment of patients with carbon
monoxide poisoning. Undersea Hyperb Med
23:215–219, 1996.
124. Behnke AR, Forbes HS, Motley EP: Circulatory and
visual effects of oxygen at 3 atmospheres pressure.
Am J Physiol 114:436–442, 1936.
125. Anderson B Jr, Farmer JC Jr: Hyperoxic myopia.
Trans Am Ophthalmol Soc 76:116–124, 1978.
126. Evanger K, Haugen OH, Irgens A, et al: Ocular
refractive changes in patients receiving hyperbaric
oxygen administered by oronasal mask or hood.
Acta Ophthalmol Scand 82:449–453, 2004.
127. Anderson B. Jr., Shelton D.L. Axial length in hype-
roxic myopia.
In
Bove AA, Bachrach AJ, Greenbaum
LJ Jr. (eds): Underwater and Hyperbaric Physiology
IX. Proceedings of the Ninth International Sympo-
sium on Underwater and Hyperbaric Physiology.
Bethesda, MD, Undersea and Hyperbaric Medical
Society, 1987, pp 607-611.
128. Koren C, Sharav T, Pastuszak A, et al: A multicenter,
prospective study of fetal outcome following acci-
dental carbon monoxide poisoning in pregnancy.
Reprod Toxicol 5:397–403, 1991.
129. Wattel F, Mathieu D, Neviere R, et al: [Carbon
monoxide poisoning]. Presse Med 25:1425–1429,
1996.
130. Plafki C, Peters P, Almeling M, et al: Complications
and side effects of hyperbaric oxygen therapy. Aviat
Space Environ Med 71:119–124, 2000.
131. Unsworth IP: Case report: Pulmonary barotrauma
in a hyperbaric chamber. Anaesthesia 28:675–678,
1973.
132. Wolf HK, Moon RE, Mitchell PR, Burger PC: Baro-
trauma and air embolism in hyperbaric oxygen
therapy. Am J Forensic Med Pathol 11:149–153,
1990.
133. Simonson SG, Pritchard RJ, Moon RE, Stolp BW:
Evaluation of two chest tube drainage systems at 2
ATA and 3 ATA. Undersea Hyperb Med
23(Suppl):124, 1996.
134. Hummel RS III, Ornato JP, Weinberg SM, Clarke
AM: Spark-generating properties of electrode gels
used during defibrillation: A potential fire hazard.
JAMA 260:3021–3024, 1988.
135. Martindale LG, Milligan M, Friese P: Test of an R-2
defibrillator adaptor in a hyperbaric chamber.
J Hyperbaric Med 2:15–25, 1987.
136. Moon RE, Hart BB: Operational use and patient
monitoring in a multiplace hyperbaric chamber.
Respir Care Clin North Am 5:21–49, 1999.
137. Van Meter K: Medical field management of the
injured diver. Respir Care Clin North Am 5:137–
177, 1999.
138. Weaver LK, Howe S: Normobaric measurement
of arterial oxygen tension in subjects exposed
to hyperbaric oxygen. Chest 102:1175–1181,
1992.
139. Moon RE, Camporesi EM, Shelton DL. Prediction
of arterial Po2 during hyperbaric treatment.
In
Bove
AA, Bachrach AJ, Greenbaum LJ Jr (eds):
Underwater and Hyperbaric Physiology IX. Procee-
dings of the Ninth International Symposium on
Underwater and Hyperbaric Physiology. Bethesda,
MD, Undersea and Hyperbaric Medical Society,
1987, pp 1127–1131.
140. Tenney SM: A theoretical analysis of the relations-
hip between venous blood and mean tissue oxygen
pressures. Respir Physiol 20:283–296, 1974.
141. McDowall DG, Ledingham IM, Tindal S: Alveolar-
arterial gradients for oxygen at 1, 2 and 3 atmosphe-
res absolute. J Appl Physiol 24:324–329, 1968.
142. Moon RE, Bergquist LV, Conklin B, Miller JN:
Monaghan 225 ventilator use under hyperbaric
conditions. Chest 89:846–851, 1986.
143. Anthonisen NR, Bradley ME, Vorosmarti J,
Linaweaver PG. Mechanics of breathing with
helium-oxygen and neon-oxygen breathing mixtu-
res in deep saturation diving. In Lambertsen CJ
(ed): Underwater Physiology IV: Proceedings of the
Fourth Symposium on Underwater Physiology.
New York Academic Press, 1971, pp 339–345.
144. Mummery HJ, Stolp BW, del Dear G, et al: Effects
of age and exercise on physiological dead space
during simulated dives at 2.8 ATA. J Appl Physiol
94:507–517, 2003.
145. Holcomb JR, Matos-Navarro AY, Goldmann RW:
Critical care in the hyperbaric chamber.
In
Davis JC,
Hunt TK (eds): Problem Wounds: The Role of
Oxygen. New York, Elsevier, 1988, pp 187–209.
146. Severinghaus JW: Hyperbaric oxygenation: Anes-
thesia and drug effects. Anesthesiology 26:812–824,
1965.
147. Churchill-Davidson I, Foster CA, Thomlinson RH:
High-pressure oxygen and radiotherapy. MedWorld
88:125–128, 1958.
148. Ross JAS, Manson HJ, Shearer A, Dundas CR: Some
aspects of anaesthesia in high pressure environ-
ments. In Smith G (ed): Proceedings of the Sixth
International Congress on Hyperbaric Medicine.
Aberdeen, Scotland, Aberdeen University Press,
1977, pp 449–452.
149. Jacobson I, Bloor K, McDowall DG, Norman JN:
Internal carotid endarterectomy at two atmosphe-
res of pressure. Lancet 2:546–549, 1963.
150. Ledingham IM, McBride TI, Jennett WB, et al: Fatal
brain damage associated with cardiomyopathy of
pregnancy, with notes on Caesarean section in a
hyperbaric chamber. BMJ 4:285–287, 1968.
151. Carter LH, Goldsmith GA: The ordeal of Donald
Boone. Nutr Today (Autumn):2–9, 1970.
152. Smith RM: Anesthesia during hyperbaric oxygena-
tion. Ann N Y Acad Sci 117:768–773, 1965.
153. Holt JAG: The principles of hyperbaric and anoxic
radiotherapy. Br J Radiol 48:819–826, 1975.
154. Russell JB, Snider MT, Richard RB, Loomis JL:
Hyperbaric nitrous oxide as a sole anesthetic agent
in humans. Anesth Analg 70:289–295, 1990.
155. Smith WDA, Mapleson WW, Siebold K, et al:
Nitrous oxide anaesthesia induced at atmospheric
and hyperbaric pressures. I. Measured pharmaco-
kinetic and EEG data. Br J Anaesth 46:3–12,
1974.
156. Hornbein TF, Eger EI II, Winter PM, et al: The
minimum alveolar concentration of nitrous oxide
in man. Anesth Analg 61:553–556, 1982.
157. Blenkarn GD, Aquadro C, Hills BA, Saltzman HA:
Urticaria following the sequential breathing of
various inert gases at a constant ambient pressure
of 7 ATA: A possible manifestation of gas-induced
osmosis. Aerosp Med 42:141–146, 1971.
158. Lambertsen CJ, Idicula J: A new gas lesion syn-
drome in man, induced by “isobaric gas counter-
diffusion”. J Appl Physiol 39:434–443, 1975.
159. Acott CJ, Gorman DF: Decompression illness and
nitrous oxide anaesthesia in a sports diver. Anaesth
Intensive Care 20:249–250, 1992.
160. McDowell DG: Anaesthesia in a pressure chamber.
Anaesthesia 19:321–336, 1964.
161. Niermeyer S, Zamudio S, Moore LG: The people.
In
Hornbein TF, Schoene RB (eds): High Altitude: An
Exploration of Human Adaptation. New York,
Marcel Dekker, 2001, pp 43–100.
162. Hackett PH: High altitude and common medical
conditions.
In
Hornbein TF, Schoene RB (eds): High
Altitude: An Exploration of Human Adaptation.
New York, Marcel Dekker, 2001, pp 839–885.
163. Wagner PD, Gale GE, Moon RE, et al: Pulmonary
gas exchange in humans exercising at sea level and
simulated altitude. J Appl Physiol 61:260–270,
1986.
164. Gale GE, Torre-Bueno JR, Moon RE, et al: Ventila-
tion-perfusion inequality in normal humans during
exercise at sea level and simulated altitude. J Appl
Physiol 58:978–988, 1985.
165. Hornbein TF, Schoene RB: High altitude. In Lenfant
C (ed): An Exploration of Human Adaptation, Lung
Biology in Health and Disease. New York, Marcel
Dekker, 2001.
166. Bärtsch P, Gibbs JS: Effect of altitude on the heart
and the lungs. Circulation 116:2191–2202, 2007.
167. West JB, Hackett PH, Maret KH, et al: Pulmonary
gas exchange on the summit of Mount Everest.
J Appl Physiol 55:678–687, 1983.
168. Bencowitz HZ, Wagner PD, West JB: Effect of
change in P50 on exercise tolerance at high altitude:
A theoretical study. J Appl Physiol 53:1487–1495,
1982.
169. Burgess KR, Johnson PL, Edwards N: Central and
obstructive sleep apnoea during ascent to high alti-
tude. Respirology 9:222–229, 2004.
170. Crow TJ, Kelman GR: Psychological effects of mild
acute hypoxia. Br J Anaesth 45:335–337, 1973.
171. Sheffield PJ, Heimbach RD: Respiratory physiology.
In
DeHart RL (ed): Fundamentals of Aerospace
Medicine. Baltimore, Williams & Wilkins, 1996,
pp 69–108.
172. Sutton JR, Reeves JT, Wagner PD, et al: Operation
Everest II: Oxygen transport during exercise at
extreme simulated altitude. J Appl Physiol 64:1309–
1321, 1988.
173. Severinghaus JW, Mitchell RA, Richardson BW,
Singer MM: Respiratory control at high altitude
suggesting active transport regulation of CSF pH. J
Appl Physiol 18:1155–1166, 1963.